Healthcare policy

President Donald Trump’s latest health‑care initiative – a nationwide discount on the high‑cost drugs used in in‑vitro fertilisation (IVF) – has drawn unexpected applause from many who normally oppose his administration. After months of behind‑the‑scenes negotiations involving pharmaceutical companies, fertility clinics, and congressional committees, the White House announced that the...

President Donald Trump’s latest agreement with pharmaceutical giants Eli Lilly and Novo Nordisk could dramatically reshape the cost landscape for obesity treatments in the United States. The deal, announced from the Oval Office, sets a sliding scale of prices that varies by dosage, specific product, and the way a patient pays—whether through...